Search

Rhea M Shields

Examiner (ID: 2487, Phone: (571)272-3848 , Office: P/2915 )

Most Active Art Unit
2915
Art Unit(s)
2915
Total Applications
3243
Issued Applications
2995
Pending Applications
31
Abandoned Applications
206

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 4463905 [patent_doc_number] => 07935515 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-03 [patent_title] => 'Recombinant microalgae cells producing novel oils' [patent_app_type] => utility [patent_app_number] => 12/628150 [patent_app_country] => US [patent_app_date] => 2009-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 16 [patent_no_of_words] => 62595 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/935/07935515.pdf [firstpage_image] =>[orig_patent_app_number] => 12628150 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/628150
Recombinant microalgae cells producing novel oils Nov 29, 2009 Issued
Array ( [id] => 7670323 [patent_doc_number] => 20110319592 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'Process for the Purification of Antibodies Using Affinity Resins Comprising Specific Ligands' [patent_app_type] => utility [patent_app_number] => 13/129009 [patent_app_country] => US [patent_app_date] => 2009-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13764 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13129009 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/129009
Process for the Purification of Antibodies Using Affinity Resins Comprising Specific Ligands Nov 12, 2009 Abandoned
Array ( [id] => 8187115 [patent_doc_number] => 20120116027 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-10 [patent_title] => 'PROCESS FOR THE PURIFICATION OF HUMAN GROWTH HORMONE POLYPEPTIDES USING AFFINITY RESINS COMPRISING SPECIFIC LIGANDS' [patent_app_type] => utility [patent_app_number] => 13/128770 [patent_app_country] => US [patent_app_date] => 2009-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 19691 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20120116027.pdf [firstpage_image] =>[orig_patent_app_number] => 13128770 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/128770
PROCESS FOR THE PURIFICATION OF HUMAN GROWTH HORMONE POLYPEPTIDES USING AFFINITY RESINS COMPRISING SPECIFIC LIGANDS Nov 12, 2009 Abandoned
Array ( [id] => 7523058 [patent_doc_number] => 08026214 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-09-27 [patent_title] => 'Liquid, aqueous pharmaceutical compositions of factor VII polypeptides' [patent_app_type] => utility [patent_app_number] => 12/617471 [patent_app_country] => US [patent_app_date] => 2009-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16397 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 218 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/026/08026214.pdf [firstpage_image] =>[orig_patent_app_number] => 12617471 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/617471
Liquid, aqueous pharmaceutical compositions of factor VII polypeptides Nov 11, 2009 Issued
Array ( [id] => 6222631 [patent_doc_number] => 20100056472 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'GRAIN COMPOSITIONS CONTAINING PRE-BIOTIC ISOMALTO-OLIGOSACCHARIDES AND METHODS OF MAKING AND USING SAME' [patent_app_type] => utility [patent_app_number] => 12/616595 [patent_app_country] => US [patent_app_date] => 2009-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 16756 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0056/20100056472.pdf [firstpage_image] =>[orig_patent_app_number] => 12616595 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/616595
Grain compositions containing pre-biotic isomalto-oligosaccharides and methods of making and using same Nov 10, 2009 Issued
Array ( [id] => 6222476 [patent_doc_number] => 20100056452 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'ANGIOGENESIS-PROMOTING SUBSTRATE' [patent_app_type] => utility [patent_app_number] => 12/615549 [patent_app_country] => US [patent_app_date] => 2009-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3675 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0056/20100056452.pdf [firstpage_image] =>[orig_patent_app_number] => 12615549 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/615549
ANGIOGENESIS-PROMOTING SUBSTRATE Nov 9, 2009 Abandoned
Array ( [id] => 6280025 [patent_doc_number] => 20100119453 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'METHODS OF ENHANCING FUNCTIONING OF THE LARGE INTESTINE' [patent_app_type] => utility [patent_app_number] => 12/581032 [patent_app_country] => US [patent_app_date] => 2009-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8269 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20100119453.pdf [firstpage_image] =>[orig_patent_app_number] => 12581032 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/581032
Methods of enhancing functioning of the large intestine Oct 15, 2009 Issued
Array ( [id] => 8955664 [patent_doc_number] => 08501436 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-06 [patent_title] => 'Method for preparation of carbamic acid (R)-1-aryl-2-tetrazolyl-ethyl ester' [patent_app_type] => utility [patent_app_number] => 12/578709 [patent_app_country] => US [patent_app_date] => 2009-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6449 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12578709 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/578709
Method for preparation of carbamic acid (R)-1-aryl-2-tetrazolyl-ethyl ester Oct 13, 2009 Issued
Array ( [id] => 7527036 [patent_doc_number] => 08043627 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-25 [patent_title] => 'Osteogenic composite matrix, method for the production thereof and implant and scaffold for tissue engineering provided with a coating formed by said osteogenic composite matrix' [patent_app_type] => utility [patent_app_number] => 12/572884 [patent_app_country] => US [patent_app_date] => 2009-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4942 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/043/08043627.pdf [firstpage_image] =>[orig_patent_app_number] => 12572884 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/572884
Osteogenic composite matrix, method for the production thereof and implant and scaffold for tissue engineering provided with a coating formed by said osteogenic composite matrix Oct 1, 2009 Issued
Array ( [id] => 4618998 [patent_doc_number] => 07998714 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-16 [patent_title] => 'Process for accelerated capture of carbon dioxide' [patent_app_type] => utility [patent_app_number] => 12/569850 [patent_app_country] => US [patent_app_date] => 2009-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 29 [patent_no_of_words] => 29818 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/998/07998714.pdf [firstpage_image] =>[orig_patent_app_number] => 12569850 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/569850
Process for accelerated capture of carbon dioxide Sep 28, 2009 Issued
Array ( [id] => 8282898 [patent_doc_number] => 08217003 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-10 [patent_title] => 'Peptide toxin formulation' [patent_app_type] => utility [patent_app_number] => 12/568400 [patent_app_country] => US [patent_app_date] => 2009-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13567 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12568400 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/568400
Peptide toxin formulation Sep 27, 2009 Issued
Array ( [id] => 6379255 [patent_doc_number] => 20100081790 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-01 [patent_title] => 'Production method of gelatin particles' [patent_app_type] => utility [patent_app_number] => 12/585834 [patent_app_country] => US [patent_app_date] => 2009-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5630 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20100081790.pdf [firstpage_image] =>[orig_patent_app_number] => 12585834 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/585834
Production method of gelatin particles Sep 24, 2009 Issued
Array ( [id] => 6596321 [patent_doc_number] => 20100062526 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-11 [patent_title] => 'OPTIMIZED MESSENGER RNA' [patent_app_type] => utility [patent_app_number] => 12/558219 [patent_app_country] => US [patent_app_date] => 2009-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 41 [patent_no_of_words] => 23973 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20100062526.pdf [firstpage_image] =>[orig_patent_app_number] => 12558219 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/558219
OPTIMIZED MESSENGER RNA Sep 10, 2009 Abandoned
Array ( [id] => 6317347 [patent_doc_number] => 20100112654 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'MICROORGANISMS FOR THE PRODUCTION OF 1,4-BUTANEDIOL' [patent_app_type] => utility [patent_app_number] => 12/556550 [patent_app_country] => US [patent_app_date] => 2009-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 55607 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20100112654.pdf [firstpage_image] =>[orig_patent_app_number] => 12556550 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/556550
Microorganisms for the production of 1,4-butanediol Sep 8, 2009 Issued
Array ( [id] => 8340325 [patent_doc_number] => 08242250 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-14 [patent_title] => 'Nucleic acid molecule encoding a cystine knot polypeptide' [patent_app_type] => utility [patent_app_number] => 12/548117 [patent_app_country] => US [patent_app_date] => 2009-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 17220 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12548117 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/548117
Nucleic acid molecule encoding a cystine knot polypeptide Aug 25, 2009 Issued
Array ( [id] => 6371569 [patent_doc_number] => 20100075379 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-25 [patent_title] => 'METHOD FOR MAKING POLYALKYLENE OXIDE MODIFIED HEMOGLOBIN' [patent_app_type] => utility [patent_app_number] => 12/536842 [patent_app_country] => US [patent_app_date] => 2009-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8097 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20100075379.pdf [firstpage_image] =>[orig_patent_app_number] => 12536842 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/536842
Method for making polyalkylene oxide modified hemoglobin Aug 5, 2009 Issued
Array ( [id] => 7586779 [patent_doc_number] => 20110281289 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-17 [patent_title] => 'QUANTIFICATION OF ENZYME ACTIVITY BY MASS SPECTROMETRY USING IMMOBILIZED SUBSTRATES' [patent_app_type] => utility [patent_app_number] => 13/003731 [patent_app_country] => US [patent_app_date] => 2009-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 17624 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20110281289.pdf [firstpage_image] =>[orig_patent_app_number] => 13003731 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/003731
QUANTIFICATION OF ENZYME ACTIVITY BY MASS SPECTROMETRY USING IMMOBILIZED SUBSTRATES Jul 12, 2009 Abandoned
Array ( [id] => 5484964 [patent_doc_number] => 20090274729 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-05 [patent_title] => 'MEDIA FOR CLOSTRIDIUM BACTERIUM AND PROCESSES FOR OBTAINING A CLOSTRIDIAL TOXIN' [patent_app_type] => utility [patent_app_number] => 12/501376 [patent_app_country] => US [patent_app_date] => 2009-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14466 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20090274729.pdf [firstpage_image] =>[orig_patent_app_number] => 12501376 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/501376
Media for clostridium bacterium and processes for obtaining a clostridial toxin Jul 9, 2009 Issued
Array ( [id] => 7730120 [patent_doc_number] => 08101718 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-24 [patent_title] => 'Methods of administering porcine B-domainless fVIII' [patent_app_type] => utility [patent_app_number] => 12/496516 [patent_app_country] => US [patent_app_date] => 2009-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11484 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/101/08101718.pdf [firstpage_image] =>[orig_patent_app_number] => 12496516 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/496516
Methods of administering porcine B-domainless fVIII Jun 30, 2009 Issued
Array ( [id] => 5474286 [patent_doc_number] => 20090247452 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-01 [patent_title] => 'PHARMACEUTICAL FORMULATIONS FOR REDUCING PAIN' [patent_app_type] => utility [patent_app_number] => 12/483673 [patent_app_country] => US [patent_app_date] => 2009-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9540 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20090247452.pdf [firstpage_image] =>[orig_patent_app_number] => 12483673 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/483673
Pharmaceutical formulations for reducing pain Jun 11, 2009 Issued
Menu